

1 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| JSL Health Capital Fund IIFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| JSL Health Capital Opportunity Fund AFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| JSL Health Capital Opportunity Fund | June 2022 | Indefinite | $47M | 85 |
| JSL Health Capital Fund I-QFiled to raise in 2021, with no closing reported yet. | 2021 | $13M | $0 | 0 |
| JSL Health Capital Fund I | August 2020 | $45M | $41M | 83 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
1 partner is named across this firm’s filings, 1 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Alexander Turkeltaub | Quiet | Digital health | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Too few companies classified yet to infer a focus. 1 of 1 portfolio companies are classified.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of JSL Health’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| 8VC | 1 | Roam Analytics |
A shared board seat: a company where filings name a JSL Health partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.